Biogen has announced that it will stop manufacturing a controversial drug for Alzheimer’s disease.
Following an internal evaluation, Biogen concluded that it would be more beneficial to allocate its resources towards the development of alternative drug candidates. | Steven Senne/AP By Lauren Gardner 01/31/2024 11:47 AM EST Updated: 01/31/2024 02:44 PM EST Biogen, a pharmaceutical company, announced on Wednesday that they will no longer pursue the development and promotion
READ MORE